> France, Germany and Italy, among other countries, now advise only one dose of vaccine for people with a healthy immune system and a confirmed previous diagnosis. Many scientists who have studied immune responses to vaccination say such policies are a sensible way to make the most of limited supplies in countries that are racing to inoculate their populations.
At least for France, their Infectious Disease professionals go further. They're of the opinion that a second dose in someone that's been infected (within a certain range of time) is subjecting them to unnecessary treatment, wasted time and side effects for no/limited benefit.
It's not to make the most of limited supplies.
Auto-translation (with some readability tweaks):
> If the second dose of vaccine has already been administered to people with a history of infection with SARS-Cov-2, the data available to date do not show any difference in the safety profile apart from the occurrence of more common systemic reactions.
https://www.has-sante.fr/jcms/p_3237271/en/strategie-de-vacc...
But questioning the value of a vaccine under any circumstances is ban-worthy in a lot of places.